Liangpunsakul Suthat, Bennett Rachel, Westerhold Chi, Ross Ruth A, Crabb David W, Lai Xianyin, Witzmann Frank A
Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA; Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.
Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Alcohol. 2014 Dec;48(8):795-800. doi: 10.1016/j.alcohol.2014.07.013. Epub 2014 Sep 28.
Patients with alcoholic liver disease have been reported to have a significantly lower percentage of body fat (%BF) than controls. The mechanism for the reduction in %BF in heavy alcohol users has not been elucidated. In adipose tissue, Pref-1 is specifically expressed in pre-adipocytes but not in adipocytes. Pref-1 inhibits adipogenesis and elevated levels are associated with reduced adipose tissue mass. We investigated the association between serum Pref-1 and %BF, alcohol consumption, and serum free fatty acids (FFA) in a well-characterized cohort of heavy alcohol users compared to controls. One hundred forty-eight subjects were prospectively recruited. The Time Line Follow-Back (TLFB) questionnaire was used to quantify the amount of alcohol consumed over the 30-day period before their enrollment. Anthropometric measurements were performed to calculate %BF. Serum Pref-1 and FFA were measured. Fifty-one subjects (mean age 32 ± 9 years, 88% men) were non-excessive drinkers whereas 97 were excessive drinkers (mean age 41 ± 18 years, 69% men). Compared to non-excessive drinkers, individuals with excessive drinking had significantly higher levels of Pref-1 (p<0.01), FFA (p < 0.001), and lower %BF (p = 0.03). Serum levels of Pref-1 were associated with the amount of alcohol consumed during the previous 30 days. Serum Pref-1 was negatively correlated with %BF, but positively associated with serum FFA. Our data suggest that elevated Pref-1 levels in excessive drinkers might inhibit the expansion of adipose tissue, decreasing %BF in alcoholics. Further work is needed to validate these findings and to better understand the role of Pref-1 and its clinical significance in subjects with heavy alcohol use.
据报道,酒精性肝病患者的体脂百分比(%BF)明显低于对照组。重度饮酒者%BF降低的机制尚未阐明。在脂肪组织中,Pref-1特异性表达于前脂肪细胞而非脂肪细胞。Pref-1抑制脂肪生成,其水平升高与脂肪组织量减少有关。我们在一组特征明确的重度饮酒者队列中,研究了血清Pref-1与%BF、酒精摄入量和血清游离脂肪酸(FFA)之间的关联,并与对照组进行比较。前瞻性招募了148名受试者。使用时间线回溯(TLFB)问卷对其入组前30天的酒精摄入量进行量化。进行人体测量以计算%BF。检测血清Pref-1和FFA。51名受试者(平均年龄32±9岁,88%为男性)为非过度饮酒者,而97名是过度饮酒者(平均年龄41±18岁,69%为男性)。与非过度饮酒者相比,过度饮酒者的Pref-1水平显著更高(p<0.01)、FFA水平显著更高(p < 0.001),而%BF更低(p = 0.03)。血清Pref-1水平与前30天的酒精摄入量有关。血清Pref-1与%BF呈负相关,但与血清FFA呈正相关。我们的数据表明,过度饮酒者中升高的Pref-1水平可能会抑制脂肪组织的扩张,降低酗酒者的%BF。需要进一步开展工作来验证这些发现,并更好地了解Pref-1在重度饮酒者中的作用及其临床意义。